Go to content
UR Home

Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation

Zimmermann, T. ; Beckebaum, S. ; Berg, C. ; Berg, T. ; Braun, F. ; Eurich, D. ; Herzer, K. ; Neumann, U. ; Rupp, C. ; Sterneck, M. ; Strassburg, C. ; Welker, M.-W. ; Zachoval, R. ; Gotthardt, D. ; Weigand, K. ; Schmidt, H. ; Wedemeyer, H. ; Galle, P. ; Zeuzem, S. ; Sarrazin, C.


With the approval of new direct acting antiviral agents (DAA), therapeutic options for patients with chronic hepatitis C virus (HCV) infection are now generally available before and after liver transplantation (LT). Interferon-free DAA regimens are highly effective therapies and provide a good safety profile. However, the body of clinical evidence in this patient population is limited and the ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons